# Larimar Therapeutics, Inc.: Form 8-K, filed Apr 11, 2022

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2022-04-11
- Accepted by EDGAR: Apr 11, 2022, 20:06 ET
- Period: 2022-04-06
- Accession: 0001193125-22-101650
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312522101650/d334496d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312522101650/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312522101650/d334496d8k.htm

Filed Apr 11, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-101650. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.